Citation: W. Bartens et al., ELEVATED LIPOPROTEIN(A) AND FIBRINOGEN SERUM LEVELS INCREASE THE CARDIOVASCULAR RISK IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS, Peritoneal dialysis international, 16(1), 1996, pp. 27-33
Citation: W. Bartens et al., FIXED ANTIHYPERTENSIVE DRUG-COMBINATION I N PATIENTS AT HIGH CARDIOVASCULAR RISK, Medizinische Klinik, 91(10), 1996, pp. 626-631
Authors:
WANNER C
BARTENS W
NAUCK M
ZAUNER I
GREIBER S
SCHOLLMEYER P
Citation: C. Wanner et al., LIPOPROTEIN(A) IN PATIENTS WITH THE NEPHROTIC SYNDROME - INFLUENCE OFIMMUNOSUPPRESSION AND PROTEINURIA, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 26-30
Authors:
WANNER C
KRAMERGUTH A
NAUCK M
QUASCHNING T
PAVENSTADT H
SCHOLLMEYER P
Citation: C. Wanner et al., CHOLESTEROL-METABOLISM IN GLOMERULAR CELLS - EFFECT OF LIPOPROTEINS FROM NEPHROTIC PATIENTS, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 39-46
Authors:
NAUCK M
KRAMERGUTH A
BARTENS W
MARZ W
WIELAND H
WANNER C
Citation: M. Nauck et al., IS THE DETERMINATION OF LDL CHOLESTEROL ACCORDING TO FRIEDEWALD ACCURATE IN CAPD AND HD PATIENTS, Clinical nephrology, 46(5), 1996, pp. 319-325
Authors:
ZIMMERMANN J
SCHRAMM L
WANNER C
MULZER E
HENRICH HA
LANGER R
HEIDBREDER E
Citation: J. Zimmermann et al., HEMORHEOLOGY, PLASMA-PROTEIN COMPOSITION AND VON-WILLEBRAND-FACTOR INTYPE-I DIABETIC NEPHROPATHY, Clinical nephrology, 46(4), 1996, pp. 230-236
Authors:
SCHRAMM L
HEIDBREDER E
LUKES M
WEIERICH T
LOPAU K
ZIMMERMANN J
WANNER C
Citation: L. Schramm et al., ENDOTOXIN-INDUCED ACUTE-RENAL-FAILURE IN THE RAT - EFFECTS OF URODILATIN AND DILTIAZEM ON RENAL-FUNCTION, Clinical nephrology, 46(2), 1996, pp. 117-124
Citation: S. Schedler et al., OXIDIZED LDL STIMULATE FORMATION OF SUPEROXIDE ANION AND RENIN SECRETION IN JUXTAGLOMERULAR CELLS - PREVENTION BY HDL, Kidney international, 50(5), 1996, pp. 1801-1802
Authors:
KRAMERGUTH A
GREIBER S
PAVENSTADT H
QUASCHNING T
WINKLER K
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., INTERACTION OF NATIVE AND OXIDIZED LIPOPROTEIN(A) WITH HUMAN MESANGIAL CELLS AND MATRIX, Kidney international, 49(5), 1996, pp. 1250-1261
Authors:
KLIEM V
WANNER C
EISENHAUER T
OLBRICHT CJ
DOLL R
BODDAERT M
OGRADY P
KREKLER M
MANGOLD B
CHRISTIANS U
Citation: V. Kliem et al., COMPARISON OF PRAVASTATIN AND LOVASTATIN IN RENAL-TRANSPLANT PATIENTSRECEIVING CYCLOSPORINE, Transplantation proceedings, 28(6), 1996, pp. 3126-3128
Authors:
OSE L
SCOTT R
BRUSCO O
UGARTE AC
DESCAMPS O
HELLER F
PAQUOT N
SCHEEN A
BERTOLAMI MC
FORTI N
RICHTER W
SELMAIER A
ZIEGLASCH HJ
KLOER H
BADE R
WANNER C
KOESTER W
KRAEMERGUTH A
BILIANOU H
LEFKOS N
EFTHIMIADIS A
KASTELEIN J
VANDAM M
VANDEWIEL A
LINTOTT C
SUNDT E
ISTAD H
LOENNECHEN CW
UTNE E
HOLE T
SKARE S
URHEIM S
CAMPODINCO S
MORALES R
IZA A
ALVAREZ L
SY R
YEBES R
LEE CY
TAN A
QUEK S
VERMAK WJH
VORSTER HH
RAAL FJ
KELLER U
NOSEDA G
BONETTI T
CRAWFORD GM
BLOOMFIELD P
SUTHERLAND K
RYLANCE PB
BROOM J
BAKSI AK
LANT AF
HUGHES EA
Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138
Authors:
BARTENS W
NAUCK M
KRAMERGUTH A
GREIBER S
GALLE J
SCHOLLMEYER P
WANNER C
Citation: W. Bartens et al., INFLUENCE OF APOPROTEIN-E PHENOTYPE ON LIPOPROTEIN(A) LEVEL AND LIPIDPROFILE IN PATIENTS WITH THE NEPHROTIC SYNDROME, Journal of the American Society of Nephrology, 6(3), 1995, pp. 381-381
Authors:
BARTENS W
ZIMMERMANN J
SCHRAMM L
HEIDBREDER E
WANNER C
Citation: W. Bartens et al., LIPOPROTEIN(A) IN PATIENTS WITH TYPE-I AND TYPE-II DIABETES-MELLITUS AND VARIOUS DEGREES OF NEPHROPATHY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 446-446
Authors:
KRAMERGUTH A
SCHOMIG M
KELLER M
BAUMSTARK MW
THIERY J
MARZ W
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., INCREASED ATHEROGENIC RISK OF DIABETIC-PATIENTS UNDERGOING HEMODIALYSIS - ROLE OF MODIFIED, TRIGLYCERIDE-RICH LIPOPROTEINS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 544-544
Authors:
KRAMERGUTH A
KELLER M
SCHOMIG M
BAUMSTARK MW
THIERY J
MARZ W
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., UPTAKE OF LDL FROM NORMOTRIGLYCERIDEMIC AND HYPERTRIGLYCERIDEMIC HEMODIALYSIS-PATIENTS HEPATOMA-CELLS AND MACROPHAGES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 544-544
Citation: J. Galle et al., HIGH-DENSITY-LIPOPROTEINS PREVENT RENIN SECRETION FROM JUXTAGLOMERULAR CELLS STIMULATED BY OXIDIZED LDL AND LP(A), Journal of the American Society of Nephrology, 6(3), 1995, pp. 620-620
Citation: J. Galle et al., ATHEROGENIC LIPOPROTEINS STIMULATE GENERATION OF SUPEROXIDE ANION IN ISOLATED ARTERIES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 658-658
Authors:
GREIBER S
KRAMERGUTH A
PAVENSTADT H
SCHOLLMEYER P
WANNER C
Citation: S. Greiber et al., INTERACTION OF NATIVE AND OXIDIZED LP(A) WITH HUMAN MESANGIAL CELLS AND MATRIX, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1013-1013
Authors:
OLBRICHT C
WANNER C
EISENHAUER T
CHRISTIANS U
KLIEM V
OGRADY P
BODDAERT M
KREKLER M
MANGOLD B
Citation: C. Olbricht et al., PRAVASTATIN AND LOVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL-TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1061-1061
Authors:
SPATH M
PAVENSTADT H
MULLER C
PETERSEN J
WANNER C
SCHOLLMEYER P
Citation: M. Spath et al., REGULATION OF PHOSPHOINOSITIDE HYDROLYSIS AND CYTOSOLIC-FREE CALCIUM-INDUCED BY ENDOTHELIN IN HUMAN GLOMERULAR EPITHELIAL-CELLS, Nephrology, dialysis, transplantation, 10(8), 1995, pp. 1299-1304
Authors:
GALLE J
SCHINI VB
STUNZ P
WANNER C
SCHOLLMEYER P
Citation: J. Galle et al., INTERLEUKIN-1-BETA INDUCES THE FORMATION OF NITRIC-OXIDE IN ISOLATED JUXTAGLOMERULAR CELLS - INFLUENCE ON RENIN SECRETION, Nephrology, dialysis, transplantation, 10(2), 1995, pp. 191-197